Drug Approval Package: Zyprexa (olanzapine)

Company:  Eli Lilly and Company
Application No.:  020592 S-035, 039, 040, 041, 049, 053, 055
021086 / S-21, 031, 032, 034
021253 / S-037, 039, 043
Approval Date: January 27, 2010

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

Date created: September 20, 2017

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English